DOI: 10.1055/s-00035024

Thrombosis and Haemostasis


Pan X, Kachroo S, Liu X. et al.
Real world discontinuation among early users of apixaban, dabigatran, rivaroxaban or warfarin among atrial fibrillation patients newly initiated on anticoagulation therapy: Tell of first 200 days [abstract].

Eur Heart J [serial online] 2014;
35 (Abstract Supplement): 897

Download Bibliographical Data

Search in: